Chimerix Inc. (NASDAQ: CMRX)
$2.9700
-0.0200 ( -5.71% ) 597.0K
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
Market Data
Open
$2.9700
Previous close
$2.9900
Volume
597.0K
Market cap
$274.31M
Day range
$2.9410 - $3.1490
52 week range
$0.7500 - $3.3900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 53 | Dec 10, 2024 |
8-k | 8K-related | 14 | Nov 14, 2024 |
8-k | 8K-related | 51 | Nov 07, 2024 |
10-q | Quarterly Reports | 53 | Nov 07, 2024 |
4 | Insider transactions | 1 | Oct 30, 2024 |
10-q | Quarterly Reports | 54 | Aug 13, 2024 |
8-k | 8K-related | 51 | Aug 13, 2024 |
4 | Insider transactions | 1 | Aug 09, 2024 |
8-k | 8K-related | 13 | Jul 03, 2024 |
8-k | 8K-related | 13 | Jun 21, 2024 |